Smith & Nephew SNATS (SNN) News
NYSE: SNNHealth CareIndustrial SpecialtiesUSD
29.830.00 (0.00%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SNN news summary
We found 45 recent headlines mentioning Smith & Nephew SNATS (SNN): 1 in the past week and 8 in the past 30 days, most often from Seeking Alpha, Nasdaq. For price context, SNN is up 0.00% at $29.83. The most recent story, "Smith & Nephew Breaks Below 200-Day Moving Average - Notable for SNN", was published by Nasdaq on Nov 17, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Smith & Nephew SNATS headlines
- Smith & Nephew Breaks Below 200-Day Moving Average - Notable for SNNIn trading on Tuesday, shares of Smith & Nephew plc (Symbol: SNN) crossed below their 200 day moving average of $30.95, changing hands as low as $30.39 per share. Smith & Nephew plc shares are…Nasdaq
- Smith & Nephew SNATS Q3 Earnings Call HighlightsSanta Rally comes early for these stocksSmith & Nephew SNATS (NYSE:SNN) lowered its full-year revenue and trading profit outlook after continued weakness in its U.S. knee and hip businesses tempered…Nasdaq
- Smith & Nephew: Sluggish Growth And Shifting Outlook Now Make It Less Attractive (Rating Downgrade)Seeking Alpha
- Smith & Nephew plc (SNN) Q3 2026 Sales/Trading Call TranscriptSeeking Alpha
- Smith & Nephew plc (SNN) Q3 2026 Sales/ Trading Statement Call - SlideshowSeeking Alpha
- Smith & Nephew plc Reports Q3 2026 Revenue of $1,551 million and Lowers Full-Year GuidanceSmith & Nephew plc reported its third quarter 2026 trading update, with revenue reaching $1,551 million, compared to $1,501 million in the third quarter of 2025. This represents 3.4% revenue growth…Nasdaq
- Smith & Nephew plc Reports Q3 2026 Revenue of $1,551 million and Revises Full-Year GuidanceSmith & Nephew plc reported its third quarter 2026 trading update, with revenue of $1,551 million compared to $1,501 million in the third quarter of 2025, representing 3.4% revenue growth on both an…NasdaqSNN, BF.B
- Smith & Nephew Q3 Revenues Rise, Cuts FY26 Outlook; Continues To Explore Options For Orthopaedics(RTTNews) - Smith & Nephew Plc (SNN, SN.L), a British medical technology company, reported Wednesday higher revenues in its third quarter, with growth in all regions. Further, the company trimmed…Nasdaq
- Smith & Nephew plc Announces Sterling Dividend Amount of 11.65 Pence per ShareSmith & Nephew plc announced that UK shareholders and those who have validly elected to receive sterling dividends will receive an interim dividend of 11.65 pence per share. As announced on 4 August…NasdaqSNN, BRK.A
- Smith+Nephew Launches CARTIHEAL Implant Across Key European MarketsSNN expands CARTIHEAL's reach across 12 European markets, backed by five-year clinical data and strong momentum in its Sports Medicine Joint Repair business.NasdaqSNN, WST, GMED, VCYT
- Smith+ Nephew's Five-Year Data Supports European Launch Of CARTIHEAL AGILI-C Implant(RTTNews) - Smith+Nephew (SNN) announced the European commercial launch of its CARTIHEAL AGILI-C Cartilage Repair Implant, an implant designed to repair cartilage damage, restore bone and help…Nasdaq
- Smith+Nephew Launches EVOS PELVIC System to Advance Trauma CareSNN expands its trauma portfolio with the EVOS PELVIC System, targeting complex pelvic and acetabular fracture procedures in the United States.NasdaqSNN, WST, GMED, VCYT
- Smith & Nephew sets $878.90 price for 2030 bond tenderSeeking Alpha
- SNN Advances Surgical Robotics Through Imperial College PartnershipSmith+Nephew's five-year Imperial College London partnership targets less invasive robotic surgery and could speed research into clinical use.NasdaqSNN, COO, WST, GMED
- Disappointing Ortho Performance Continues To Hold Smith & Nephew Back (Downgrade)Seeking Alpha
- Smith+Nephew Launches FLOW FLEXTEND COBLATION Wand for Hip SurgerySNN launches the FLOW FLEXTEND COBLATION Wand, offering adjustable-angle access and precise tissue removal in complex joint procedures.NasdaqSNN, COO, WST, GMED
- Smith & Nephew SNATS Q2 Earnings Call HighlightsSanta Rally comes early for these stocksSmith & Nephew SNATS (NYSE:SNN) reported second-quarter underlying revenue growth of 1.6%, below management’s expectations, as continued strength in…Nasdaq
- Smith & Nephew (SNN) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Smith & Nephew plc (SNN) Q2 2026 Earnings Call TranscriptSeeking Alpha
- Smith & Nephew plc 2026 Q2 - Results - Earnings Call PresentationSeeking Alpha
- Smith & Nephew H1 Profit Rises(RTTNews) - Smith & Nephew Plc (SNN, SN.L) reported that its first half profit before tax totaled $380 million compared to $362 million, a year ago. For the half year ended June 27, 2026,…Nasdaq
- Smith+Nephew Expands ASC Platform to Support Value-Based CareSNN expands ASC Solutions with an integrated platform, analytics and partners to boost efficiency, growth and patient outcomes in outpatient care.NasdaqSNN, ISRG, CAH, WST
- Smith+Nephew Launches LYNX COBLATION Wand for ENT Airway SurgerySNN launches the LYNX COBLATION Laryngeal Wand, combining precise dissection, rapid debulking and hemostasis for airway procedures.NasdaqSNN, ISRG, CAH, WST
- Smith & Nephew: Ongoing Business Progress And A More Attractive PriceSeeking Alpha
- Smith & Nephew plc (SNN) Shareholder/Analyst Call TranscriptSeeking Alpha
- Smith & Nephew plc (SNN) Shareholder/Analyst Call - SlideshowSeeking Alpha
- VEEV Boosts MedTech Quality Management With Smith+Nephew PartnershipVeeva Systems expands its medtech reach as Smith+Nephew adopts Veeva Quality Cloud to modernize global quality operations and training.NasdaqSNN, WST, GMED, VEEV
- Smith & Nephew To Repurchase Up To $250 Mln Of Shares(RTTNews) - Smith & Nephew PLC (SNN, SN.L), a medical technology company, said on Friday that it has inked a deal with Merrill Lynch International to repurchase up to $250 million of shares at $0.20…Nasdaq
- Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call TranscriptSeeking Alpha
- Smith & Nephew plc (SNN) Q1 2026 Sales/ Trading Statement Call - SlideshowSeeking Alpha
- SNN vs. BSX: Which Stock Is the Better Value Option?SNN vs. BSX: Which Stock Is the Better Value Option?NasdaqSNN, BSX
- SNN's CARTIHEAL Cartilage Implant Beats Standard Care in 5-Year StudySmith+Nephew's CARTIHEAL implant shows superior 5-year outcomes vs. standard care, with a new CPT code set to boost adoption and expand cartilage repair reach.NasdaqSNN, CAH, GMED, PAHC
- Smith & Nephew Breaks Above 200-Day Moving Average - Bullish for SNNIn trading on Tuesday, shares of Smith & Nephew plc (Symbol: SNN) crossed above their 200 day moving average of $34.14, changing hands as high as $34.41 per share. Smith & Nephew plc shares are…Nasdaq
- Smith & Nephew plc (SNN) Q4 2025 Earnings Call TranscriptSeeking Alpha
- Smith & Nephew plc 2025 Q4 - Results - Earnings Call PresentationSeeking Alpha
- Smith & Nephew: Improving And Undervalued, But Mind The KneesSeeking Alpha
- Smith & Nephew plc (SNN) Analyst/Investor Day TranscriptSeeking Alpha
- Smith & Nephew plc (SNN) Analyst/Investor Day - SlideshowSeeking Alpha
- Smith & Nephew plc (SNN) Analyst/Investor Day TranscriptSeeking Alpha
- Smith & Nephew plc (SNN) Q3 2025 Sales/Trading Call TranscriptSeeking Alpha
- Smith & Nephew plc (SNN) Q3 2025 Sales/ Trading Statement Call - SlideshowSeeking Alpha
- Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings ReleaseSeeking Alpha
- Smith & Nephew: Doing Better And Still Offers ValueSeeking Alpha
- Smith & Nephew plc 2025 Q2 - Results - Earnings Call PresentationSeeking Alpha
- Smith & Nephew plc (SNN) Q2 2025 Earnings Call TranscriptSeeking Alpha